Rovero P, Riganelli D, Fruci D, Viganò S, Pegoŕaro S, Revoltella R, Greco G, Butler R, Clementi S, Tanigaki N
Istituto di Mutagenesi e Differenziamento, CNR, Pisa, Italy.
Mol Immunol. 1994 May;31(7):549-54. doi: 10.1016/0161-5890(94)90042-6.
In this paper we report a chemometric approach to Quantitative Structure-Activity Relationship (QSAR) analysis applied to a study of the binding of peptides to Major Histocompatibility Complex (MHC) class I proteins. Peptides which possess the known primary anchor residue motif for HLA-B27 binding do not necessarily bind to HLA-B27 proteins. Secondary anchor residues are also involved, but it is not yet clear which amino acids are required or in which positions. A classic approach to this problem would be to synthesize multiple peptides each varying by a single amino acid from a starting peptide, and test them for their binding properties. Not only is this approach inefficient, but it is essentially unable to provide information about possible mutual interactions of amino acid residues in different positions. Using a statistical design to select the most informative compounds to use in the QSAR study, it was possible to analyse the effects on HLA-B27 peptide binding of different amino acids in four positions by means of only nine peptides. The relative binding activity of these peptides could then be modeled mathematically to provide information about the relative contribution of each of the four positions and to suggest a new peptide with high binding affinity. Our results demonstrate the usefulness of the chemometric strategy for studying peptides of interest in molecular immunology.
在本文中,我们报告了一种化学计量学方法,用于定量构效关系(QSAR)分析,该方法应用于研究肽与主要组织相容性复合体(MHC)I类蛋白的结合。具有已知的HLA - B27结合主要锚定残基基序的肽不一定能与HLA - B27蛋白结合。二级锚定残基也参与其中,但尚不清楚需要哪些氨基酸或它们处于哪些位置。解决这个问题的经典方法是合成多个肽,每个肽与起始肽相比仅在一个氨基酸上有所不同,并测试它们的结合特性。这种方法不仅效率低下,而且基本上无法提供不同位置氨基酸残基可能的相互作用信息。通过使用统计设计来选择在QSAR研究中使用的信息最丰富的化合物,仅用九个肽就有可能分析四个位置上不同氨基酸对HLA - B27肽结合的影响。然后可以对这些肽的相对结合活性进行数学建模,以提供有关四个位置中每个位置的相对贡献的信息,并提出一种具有高结合亲和力的新肽。我们的结果证明了化学计量学策略在研究分子免疫学中感兴趣的肽方面的有用性。